Cite
HARVARD Citation
Dreesen, E. et al. (2018). Anti‐infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response. Alimentary pharmacology & therapeutics. 47 (3), pp. 346-355. [Online].